Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2025Journal of Inorganic BiochemistryOpen Access

New oxaliplatin-zoledronate derivatives with potential antitumor activity towards bone tumors and metastases

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAlessandra BarbanenteACAnna Maria Di CosolaMNMauro Niso

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barbanente et al. (2025) studied this question.

synapsesocial.com/papers/6aa228ea2fd346a5956eea06https://doi.org/10.1016/j.jinorgbio.2025.112916
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients2016 · 29 citations
  2. 2Current Overview of Treatment for Metastatic Bone Disease2021 · 145 citations
  3. 3Interaction of human telomeric DNA with N- methyl mesoporphyrin IX2012 · 241 citations
  4. 4Dinuclear Pt(ii)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs2012 · 28 citations
  5. 5Revisiting [PtCl<sub>2</sub>(<i>cis</i>-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer2012 · 78 citations